Get the Stockscreener App
0.0004
33.33%
0.0001
Ocean Biomedical Inc stock is traded at $0.0004, with a volume of 2,621.
It is up +33.33% in the last 24 hours and up +100.00% over the past month.
See More
Previous Close:
$0.0003
Open:
$0.0001
24h Volume:
2,621
Relative Volume:
0.06
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-30.72M
P/E Ratio:
-0.000439
EPS:
-0.9105
Net Cash Flow:
$-4.05M
1W Performance:
+33.33%
1M Performance:
+100.00%
6M Performance:
-86.21%
1Y Performance:
-99.22%
1-Day Range:
$0.0001
$0.0004
1-Week Range:
$0.0001
$0.0004
52-Week Range:
$0.0001
$0.0068
Ocean Biomedical Inc Stock (OCEA) Company Profile
Compare OCEA vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.0004 | 0 | 0 | -30.72M | -4.05M | -0.9105 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Ocean Biomedical Inc Stock (OCEA) Latest News
Enterprise value to revenue forward of Ocean Biomedical, Inc. – MUN:8AW0 - TradingView
Price to sales forward of Ocean Biomedical, Inc. – MUN:8AW0 - TradingView
Price to book forward of Ocean Biomedical, Inc. – MUN:8AW0 - TradingView
Price to earnings forward of Ocean Biomedical, Inc. – MUN:8AW0 - TradingView
If You Invested $1,000 in Axim Biotechnologies Inc (AXIM) - Stock Titan
If You Invested $1,000 in Entheon Biomedic (ENTBF) - Stock Titan
If You Invested $1,000 in Regen Biopharma (RGBPP) - Stock Titan
Impact BioMedical, Inc. Financial Disclosures & SEC Filings - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView
LFCR Forecast — Price Target — Prediction for 2027 - TradingView
Ocean Biomedical, Inc. Actuals & Estimates (OTC:OCEA) - TradingView
Ocean Biomedical, Inc. Actuals & Estimates (MUN:8AW0) - TradingView
Price to earnings forward of Impact BioMedical, Inc. – BOATS:IBO - TradingView
Ocean Spray Names Former Nestlé Health Science Executive Abigail Buckwalter as CEO - Nutritional Outlook
Biomedical Co. Clearside Gets OK For $4M Ch. 11 Sale - Law360
Deep-sea fish's light-scattering crystals could inspire new biomedical devices - Interesting Engineering
Ocean Biomedical, Inc.Common Stock (NQ: OCEA - The Chronicle-Journal
DcashLanzillotta.166300 User Profile @ StockInvest.us - StockInvest.us
Ocean Biomedical, Inc. (OCEAW) - Minichart
Stock List: Research Stocks from Around the World - GuruFocus
OCEA (Ocean Biomedical) PB Ratio : (As of Apr. 07, 2026) - GuruFocus
OCEAW (Ocean Biomedical) PB Ratio : (As of Apr. 04, 2026) - GuruFocus
Top 10 Best Paying Marine Biology Jobs 2026 (Inc Salaries) - Nexford University
Ocean Biomedical, Inc. (OCEA) stock price, news, quote and history - Yahoo Finance UK
LakeShore Biopharma Co., Ltd (LSBWF) stock price, news, quote and history - Yahoo Finance UK
Ocean Biomedical expands into energy and digital asset sectors - MSN
Biotech Companies are Coming to Life at Ocean State Labs - Rhode Island Monthly
Pharmaceutical companies move away from horseshoe crab biomedical testingnews - news - Mongabay
OCEAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
OCEA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Clearside Bio Wants Block On $100M Bid That 'Froze' Auction - Law360
How forex fluctuations impact Ocean Biomedical Inc. (8AW0) stockJuly 2025 Reactions & Smart Allocation Stock Tips - mfd.ru
Orthocell lifts Marine Biomedical stake, locks in rights to PearlBone bone substitute | ASX:OCC, OTC:ORHHF - Proactive financial news
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket - Intellectia AI
why is ocea stock dropping: causes & outlook - Bitget
OCEA Stock Price, Quote and News - Markets.com
Clearside Biomedical receives court approval for asset sale bidding procedures - Investing.com
Amira’s AMI-463 demonstrates 60% tumor reduction in mouse model - bioworld.com
India's first deep sea marine microbial research facility coming up in Andhra's Nellore - The Economic Times
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
CLSDQ Stock Price and Chart — OTC:CLSDQ - TradingView
Ocean Dx sepsis test matches gold standard in early study - BioWorld News
Orthocell ups Marine Biomedical stake, targeting PearlBone™ global rights and the US$1.6BN bone substitutes market - Proactive financial news
Idiopathic Pulmonary Fibrosis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail
SPACs, Executives Beat Investor’s Shell Company Accusations (1) - Bloomberg Law News
Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG - Investing.com
From Ocean to Industry: How Fresh on Time Seafood Excels as a Chitosan Manufacturer - Digital Journal
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Ocean Biomedical to be delisted from Nasdaq following appeal denial - Investing.com
Ocean Biomedical licenses with Elkurt terminated following breach notice - Investing.com
Horseshoe crabs belong in the ocean, not in labs - Humane World for Animals
Ocean Biomedical Inc Stock (OCEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
2.11%
Cap:
|
Volume (24h):